Boehringer Ingelheim, in collaboration with Emirates Thoracic Society (ETS) and social media influencer Ghaith Marwan, ...

Boehringer Ingelheim, a leading biopharmaceutical company, has teamed up with the Emirates Thoracic Society (ETS) and social ...

When you visit Dubai Miracle Garden next, you will encounter an 'impossible-to-ignore' installation with an important health ...

The following is a summary of “Tacrolimus as first line therapy in a U.S. cohort of idiopathic inflammatory myopathies ...

Understanding resilience—the ability of injured lung tissue to heal and regenerate—may be key to advancing the treatment and ...

Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

The median length of survival for individuals with ILD who completed pulmonary rehabilitation was 6.1 years vs 4.7 years in the control group. Pulmonary rehabilitation (PR) may improve survival at 5 ...

Coreline Soft will demonstrate its cutting-edge AI-based lung and thoracic imaging solution lineup at the Society of Thoracic Radiology 2025 (STR) on March 1st. STR is an international academic event ...

Which of the statements about the guideline for the screening and monitoring of interstitial lung disease among patients with systemic autoimmune rheumatic diseases are correct?

Cystic Fibrosis Damages the Immune System Early on Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease ...